ArticleBMJ open2024

Protocol for a double-blind placebo-controlled randomised controlled trial assessing the impact of oral semaglutide in amyloid positivity (ISAP) in community dwelling UK adults.

Ivan Koychev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.